A University of Manitoba-led study has successfully eliminated breast-cancer-derived brain tumors in mice, using a drug to penetrate the brain and eliminate metastatic brain tumors. After testing ...

Barclays raised the firm’s price target on Quest Diagnostics (DGX) to $185 from $175 and keeps an Equal Weight rating on the shares. The company’s “strong” Q1 reinforces Quest “as a ...

A recently published study has identified collagen type X α 1 chain (CoL10A1) as a promising target for treating brain metastasis in breast cancer patients. The research, conducted by a team at First ...

COLUMBUS, Ohio – Researchers have found that targeting an enzyme called PGM3 can help stop the growth of glioblastoma, the most dangerous type of brain tumor ... found a new target called ...

For Engert to suggest that the president’s brain quest was bunk was a bit like John Glenn returning from orbit and telling JFK not to bother with a lunar landing. “He should be an advocate ...